Hubungan Komorbid dengan Outcome Pasien Terkonfirmasi COVID-19 Di RSUP M. Djamil Padang Tahun 2020
Abstract
Tujuan : Penelitian bertujuan Untuk mengetahui hubungan komorbid dengan outcome pasien terkonfirmasi COVID-19 di RSUP. M. Djamil Padang tahun 2020. Metode : Penelitian bersifat analitik observasional dengan pendekatan cross sectional. Data dikumpulkan dan diolah dengan menggunakan teknik total sampling , yaitu semua pasien terkonfirmasi COVID-19 yang dirawat di RSUP M.Djamil Padang berdasarkan kriteria inklusi dan ekslusi . Jumlah sampel penelitian sebanyak 468 pasien terkonfimasi COVID-19 yang dirawat pada periode Maret – Desember 2020. Analisis yang digunakan adalah analisis bivariat berupa Chi-Square . Hasil: Hasil penelitian menunjukkan terdapat hubungan yang signifikan antara komorbid dengan outcome pada pasien terkonfirmasi COVID-19 (p=0,010) di RSUP. M.Djamil Padang. Kesimpulan : Berdasarkan hasil penelitian dapat diartikan bahwa terdapat hubungan antara komorbid dengan outcome pada pasien terkonfirmasi COVID-19.
Full Text:
PDFReferences
Guo YR, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):1-10
Kementrian Kesehatan Republik Indonesia/Kementrian Kesehatan RI. Pencegahan pengendalian COVID-19. Kemenkes RI. 2019;4:1-214.
Kementrian Kesehatan Republik Indonesia. Infeksi emerging. Kemenkes RI. 2022.
World Health Organization. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. WHO. 2021;1–5.
Kurniawan E. Info Covid-19 Sumbar, Sabtu 12 Desember 2020. Portal Resmi Provinsi Sumatera Barat. 2020.
Kementrian Kesehatan Republik Indonesia. Covid dalam angka per 12 Desember 2020. Kemenkes RI. 2020.
Dorland WA, Newman. Kamus Kedokteran Dorland. Buku kedokteran EGC. 2010;31
Satuan Tugas Penanganan COVID-19. Peta Sebaran COVID19. Satgas Penanganan COVID-19. 2022;1.
Mullen B. COVID-19 clinical guidance for the cardiovascular care team. J Am Coll Cardiol. 2020;44:1-4.
Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36(7):1–9.
Ge E, Li Y, Wu S, Candido E, Wei X. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. PLoS One. 2021;16(10):1–18.
Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, El Burai Felix S, et al. Coronavirus Disease 2019 Case Surveillance - United States.2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759
Wen S, Prasad A, Freeland K, Podury S, Patel J, Subedi R, et al. Clinical characteristics and outcomes of covid‐19 in west virginia. Viruses. 2021;13(5):1–14.
Das SK. The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19). Indian J Clin Biochem. 2020;35(4):385–96.
Widjaja JT, Kwee L, Giantara AK, Suabgiyo HA, Edwin C, Putri RL. Karakteristik Pasien COVID-19 Rawat Inap di RS Immanuel Bandung, Indonesia. J Med Heal. 2021;3(2):164–75.
Pietrobon AJ, Teixeira FME, Sato MN. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People. Vol. 11, Frontiers in Immunology. 2020.
Juwita SS, Anggraini D, Kurniawati D. Gambaran Karakteristik Pasien Covid-19 Di Rumah Sakit Otak Dr. Mohammad Hatta Bukittinggi. Afiyah. 2022;9(1):1-5).
Hughes-Visentin A, Paul ABM. Asthma and COVID-19: what do we know now. Clin Med Insights Circ Respir Pulm Med. 2020;14:1-7.
Drefahl S, Wallace M, Mussino E, Aradhya S, Kolk M, Brandén M, et al. A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden. Nat Commun. 2020;11(1):1–720.
Rahman FS, Heriyani F, Nurrasyidah I, Noor MS, Washilah S. Hubungan tingkat pendidikan dan pekerjaan dengan kejadian Covid-19 di Puskemas Pemurus Dalam Kota Banjarmasin. Homeostasis. 2022;5(1):1-10.
Upik N, Masrika E, Hasan M, Yusran Y, Buyung S. Karakteristik Pasien COVID -19 di Rumah Sakit Umum Daerah Dr . H . Chasan Boesoirie. Jumantik. 2022;7(3):255–65.
Akhtar H, Khalid S, ur Rahman F, Umar M, Ali S, Afridi M, et al. Presenting Characteristics, Comorbidities, and Outcomes among Patients with COVID-19 Hospitalized in Pakistan: Retrospective Observational Study. JMIR Public Heal Surveill 2021;7(12):e32203.
Ye C, Zhang S, Zhang X, Cai H, Gu J, Lian J, et al. Impact of comorbidities on patients with COVID-19: a large retrospective study in Zhejiang, China. J Med Virol. 2020;92:2821–9.
Nugraha MD, Trisyani Y, Mirwanti R. Analisis faktor risiko kematian akibat infeksi COVID-19. Jurnal Ilmu Kesehatan Bhakti Husada: Health Science Journal. 2021;12(2):204–14.
Parra-Bracamonte GM, Lopez-Villalobos N, Parra-Bracamonte FE. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico. Ann Epidemiol. 2020;52:93-98.
Indriyani N, Sabri YS, Afriani A. Association Between Comorbidities and Outcome of COVID-19 Patients at dr. M. Djamil General Hospital Padang. Respir Sci. 2022;3(1):38–50.
Rahayu LA, Admiyanti JC, Khalda YI, Adha FR, Agistany NFF. Hipertensi, diabetes melitus dan obesitas sebagai faktor komorbiditas utama terhadap mortalitas pasien covid-19 : sebuah studi literatur. Jurnal Ilmiah Mahasiswa Kedokteran Indonesia. 2021;9:90–7.
Pititto B A, Ferreira SRG. Diabetes and covid-19: more than the sum of two morbidities. Rev Saude Publica. 2020;54:54.
Scheen AJ. DPP-4 inhibition and COVID-19: From initial concerns to recent expectations. Diabetes Metab. 2021;47(2):101213.
Yulia R, Surabaya U, Herawati F, Surabaya U. Profil Penggunaan Obat pada Pasien Covid -19 di Ruang Isolasi Rumah Sakit X Kabupaten Malang. 2022;11:2870-8.
Burhan E, Susanto AD, Nasution SA, Ginanjar E, Pitoyo CW, Susilo A, et al. Pedoman Tatalaksana COVID-19. PDPI, PERKI, PAPDI, PERDATIN, IDAI. 2020;1:50.
Putra IMAA. Hubungan Komorbiditas Terhadap Derajat keparahan Admisi dan Outcome Pasien COVID-19 di Rumah Sakit Bethesda Yogyakarta. Nuevos Sist Comun e Inf. 2021;2013–5.
Czernichow S, Beeker N, Rives-Lange C, Guerot E, Diehl JL, Katsahian S, et al. Obesity doubles mortality in patients hospitalized for severe acute respiratory syndrome coronavirus 2 in Paris Hospitals, France: a cohort study on 5,795 patients. Obesity. 2020;12:2282–9.
